Keith L. Knutson

24.7k total citations · 3 hit papers
187 papers, 14.3k citations indexed

About

Keith L. Knutson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Keith L. Knutson has authored 187 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Immunology, 99 papers in Oncology and 49 papers in Molecular Biology. Recurrent topics in Keith L. Knutson's work include Immunotherapy and Immune Responses (87 papers), Cancer Immunotherapy and Biomarkers (54 papers) and Monoclonal and Polyclonal Antibodies Research (37 papers). Keith L. Knutson is often cited by papers focused on Immunotherapy and Immune Responses (87 papers), Cancer Immunotherapy and Biomarkers (54 papers) and Monoclonal and Polyclonal Antibodies Research (37 papers). Keith L. Knutson collaborates with scholars based in United States, Canada and United Kingdom. Keith L. Knutson's co-authors include Mary L. Disis, Kathy Schiffman, Kimberly R. Kalli, Marshall D. Behrens, Derek C. Radisky, Lynn C. Hartmann, Lavakumar Karyampudi, Yanyan Lou, Bhagirathbhai Dholaria and Aixa Soyano and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Keith L. Knutson

184 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments

2009 3.5k citations Keith L. Knutson et al. profile →
Next generation of immune checkpoint therapy in cancer: new developments and challenges

2018 608 citations Keith L. Knutson, Saranya Chumsri et al. profile →
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

2005 545 citations Keith L. Knutson, Mary L. Disis profile →

Peers

Countries citing papers authored by Keith L. Knutson

Since Specialization

Citations

This map shows the geographic impact of Keith L. Knutson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith L. Knutson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith L. Knutson more than expected).

Fields of papers citing papers by Keith L. Knutson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith L. Knutson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith L. Knutson. The network helps show where Keith L. Knutson may publish in the future.

Co-authorship network of co-authors of Keith L. Knutson

This figure shows the co-authorship network connecting the top 25 collaborators of Keith L. Knutson. A scholar is included among the top collaborators of Keith L. Knutson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith L. Knutson. Keith L. Knutson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular markers of proliferation, DNA repair, and immune infiltration defines high-risk subset of resectable retroperitoneal sarcomas 2024 ·Surgical Oncology ·Nathan D. Seligson, Yan W. Asmann, (unknown), (unknown), Mark Edgar, Steven Attia, Keith L. Knutson, Sanjay P. Bagaria	1
2	BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression 2024 ·Frontiers in Endocrinology ·(unknown), Michael Rivera, (unknown), Asha Nair, Yi Liu, Xue Wang, Brian M. Necela, Jennifer M. Kachergus, John D. Casler, (unknown), (unknown), Victor Bernet, John A. Copland, Keith L. Knutson, (unknown), Robert C. Smallridge	0
3	Comprehensive profiling of cancer neoantigens from aberrant RNA splicing 2024 ·Journal for ImmunoTherapy of Cancer ·Daniel P. Wickland, (unknown), Erik Jessen, Brian M. Necela, (unknown), Yi Lin, Keith L. Knutson, Yan W. Asmann	4
4	T-cell immune cluster analysis using CyTOF identifies unique subgroups of patients with acute myeloid leukemia 2024 ·Blood Advances ·Talha Badar, Keith L. Knutson, James M. Foran, Naseema Gangat, Kevin D. Pavelko, Scott H. Kaufmann, Mark R. Litzow, Hemant S. Murthy, (unknown), (unknown), (unknown), Aref Al‐Kali, Hassan B. Alkhateeb, Ayalew Tefferi, Mrinal M. Patnaik, Mithun Vinod Shah	6
5	Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients 2023 ·Frontiers in Immunology ·(unknown), Gabriel Figueroa‐Parra, Xian Zhou, Yanfeng Li, (unknown), (unknown), (unknown), Kenneth J. Warrington, Cornelia M. Weyand, Cynthia S. Crowson, Saranya Chumsri, Keith L. Knutson, (unknown), Uma Thanarajasingam, Alí Duarte‐García, Hu Zeng	5
6	Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination 2022 ·Inflammatory Bowel Diseases ·Freddy Caldera, Francis A. Farraye, Brian M. Necela, (unknown), Sumona Saha, Arnold Wald, (unknown), Kelly Chun, Ian Grimes, (unknown), (unknown), Melanie D. Swift, Abinash Virk, Adil E. Bharucha, Tushar Patel, Gregory J. Gores, Saranya Chumsri, Mary S. Hayney, Keith L. Knutson	11
7	Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease 2022 ·Inflammatory Bowel Diseases ·(unknown), Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep Phan, (unknown), Kelly Chun, Ian Grimes, (unknown), Mary S. Hayney, Francis A. Farraye, Freddy Caldera	16
8	Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients 2018 ·Clinical Cancer Research ·Kimberly R. Kalli, Matthew S. Block, Pashtoon Murtaza Kasi, Courtney L. Erskine, Timothy J. Hobday, Allan B. Dietz, Douglas Padley, Michael P. Gustafson, Barath Shreeder, (unknown), (unknown), (unknown), (unknown), Keith L. Knutson	72
9	Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development 2017 ·Clinical Cancer Research ·Amy C. Degnim, Tanya L. Hoskin, (unknown), Marlene H. Frost, Stacey J. Winham, (unknown), (unknown), Jodi M. Carter, Melody Stallings‐Mann, Linda M. Murphy, Erin Miller, (unknown), Celine M. Vachon, Keith L. Knutson, Derek C. Radisky, Daniel W. Visscher	46
10	IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer 2017 ·Cancer Research ·Purushottam Lamichhane, Lavakumar Karyampudi, Barath Shreeder, James Krempski, (unknown), (unknown), Kimberly R. Kalli, Ellen L. Goode, Matthew S. Block, Martin J. Cannon, Keith L. Knutson	122
11	PD-1 Blunts the Function of Ovarian Tumor–Infiltrating Dendritic Cells by Inactivating NF-κB 2015 ·Cancer Research ·Lavakumar Karyampudi, Purushottam Lamichhane, James Krempski, Kimberly R. Kalli, Marshall D. Behrens, (unknown), Lynn C. Hartmann, Jo Marie Tran Janco, Haidong Dong, Karen E. Hedin, Allan B. Dietz, Ellen L. Goode, Keith L. Knutson	86
12	Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831 2014 ·Cancer Immunology Research ·Nadine Norton, (unknown), Mark D. Pegram, Kathleen Tenner, Karla V. Ballman, Raphael Clynes, Keith L. Knutson, Edith A. Perez	34
13	Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody 2014 ·Cancer Research ·Lavakumar Karyampudi, Purushottam Lamichhane, Adam D. Scheid, Kimberly R. Kalli, Barath Shreeder, James Krempski, Marshall D. Behrens, Keith L. Knutson	120
14	Utility of Progranulin and Serum Leukocyte Protease Inhibitor as Diagnostic and Prognostic Biomarkers in Ovarian Cancer 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Aaron Carlson, Matthew J. Maurer, Krista M. Goergen, Kimberly R. Kalli, Courtney L. Erskine, Marshall D. Behrens, Keith L. Knutson, Matthew S. Block	31
15	Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System 2012 ·Journal of Visualized Experiments ·Courtney L. Erskine, (unknown), Keith L. Knutson	14
16	Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells 2009 ·Cancer Research ·Marta Santisteban, Jennifer M. Reiman, Michael K. Asiedu, Marshall D. Behrens, Aziza Nassar, Kimberly R. Kalli, Paul Haluska, James N. Ingle, Lynn C. Hartmann, Masoud H. Manjili, Derek C. Radisky, Soldano Ferrone, Keith L. Knutson	320
17	Signatures Associated with Rejection or Recurrence in HER-2/ neu –Positive Mammary Tumors 2008 ·Cancer Research ·Andrea Worschech, Maciej Kmieciak, Keith L. Knutson, Harry D. Bear, Aladar A. Szalay, Ena Wang, Francesco M. Marincola, Masoud H. Manjili	32
18	In vitro organotypic co-culture model for the study of bronchial epithelial clonal outgrowth during multistep lung tumorigenesis. 2004 ·Cancer Research ·Keith L. Knutson, Jason Lukas, Bond Almand, Yushe Dang, Mary L. Disis	1
19	Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity. 2002 ·PubMed ·Keith L. Knutson, Kathy Schiffman, Martin A. Cheever, Mary L. Disis	198
20	Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization. 2000 ·PubMed ·(unknown), K Schiffman, Ted Gooley, Douglas G. McNeel, Kristine Rinn, Keith L. Knutson	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact